- Medicenna Therapeutics Corp MDNA11 Clinical Update Call TranscriptAug 09, 2023
- Medicenna Therapeutics Corp at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Medicenna Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Medicenna Therapeutics Corp at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 09, 2023
- Q3 2023 Medicenna Therapeutics Corp Earnings Call TranscriptFeb 07, 2023$0.751 (-1.83%)Earnings
- Q2 2023 Medicenna Therapeutics Corp Earnings Call TranscriptNov 04, 2022$0.646 (-3.15%)Earnings
- Medicenna Therapeutics Corp Annual Shareholders Meeting TranscriptSep 21, 2022
- Q1 2023 Medicenna Therapeutics Corp Earnings Call TranscriptAug 15, 2022$0.98 (-8.41%)Earnings
- Q4 2022 Medicenna Therapeutics Corp Earnings Call TranscriptJun 22, 2022$0.9755 (+15.31%)Earnings
- Medicenna Therapeutics Corp at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 02, 2022
- Q3 2022 Medicenna Therapeutics Corp Earnings Call TranscriptFeb 09, 2022$1.87 (+1.08%)Earnings
- Q2 2022 Medicenna Therapeutics Corp Earnings Call TranscriptNov 12, 2021$2.05 (+0.74%)Earnings
- Medicenna Therapeutics Corp Annual Shareholders Meeting TranscriptSep 23, 2021
- Medicenna Therapeutics Corp at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Q1 2022 Medicenna Therapeutics Corp Earnings Call TranscriptAug 13, 2021$2.04 (-6.42%)Earnings
- Medicenna Therapeutics Corp MDNA11 Program Update Call TranscriptJul 27, 2021
- Q4 2021 Medicenna Therapeutics Corp Earnings Call TranscriptMay 28, 2021$3.89 (+1.83%)Earnings
- Medicenna Therapeutics Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Medicenna Therapeutics Corp. - Special Call TranscriptDec 11, 2020
- Medicenna Therapeutics Corp. - Special Call TranscriptMar 25, 2020
- Medicenna Therapeutics Corp to Host Key Opinion Leader Call Focused on Latest MDNA55 Recurrent Glioblastoma Phase 2b Clinical Study Results TranscriptNov 25, 2019
Q3 2022 Medicenna Therapeutics Corp Earnings Call Transcript
Greetings, and welcome to Medicenna Therapeutics Third Quarter Fiscal 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Dan Ferry of LifeSci Advisors. Please go ahead.
Thank you, operator, and thank you all for participating in today's conference call. This morning, Medicenna issued a press release providing financial results and corporate updates for the quarter ended December 31, 2021. If you have not seen the press release, it is available on the Investors page of Medicenna's website.
Before we begin, I would like to remind you that certain statements and information shared during this call constitute forward-looking information within the meaning of applicable securities laws and relate to the future operations of the company and other statements that are not historical facts, including statements related to the clinical potential and development of the MDNA11
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)